#Synthetic Genomics Inc

[meditechinsight01]

Global CRISPR Technology Market to Rise at 16% CAGR with Increased CRISPR-Cas9 Adoption by 2030

The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous advancements in CRISPR technology; rising demand for precise and efficient gene-editing tools and therapies; growing prevalence of genetic disorders; significant investments from governments, private companies, and venture capitalists; collaborations between academic institutions, biotechnology companies, and pharmaceutical firms; and integration with other technologies like artificial intelligence (AI) and nanotechnology are some of the key factors driving the CRISPR technology market growth.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary gene-editing technology derived from bacterial defense mechanisms. It uses the Cas9 (or other Cas proteins) enzyme to precisely cut DNA at targeted locations, allowing for gene modification, deletion, or replacement. CRISPR has transformed genetic research, enabling advancements in medicine, agriculture, and biotechnology. It holds promise for treating genetic disorders, developing disease-resistant crops, and advancing synthetic biology. However, challenges like ethical concerns, off-target effects, and regulatory hurdles remain. Despite these, CRISPR continues to drive innovation in gene therapy, drug discovery, and personalized medicine, shaping the future of biotechnology.

Unlock key findings! Fill out a quick inquiry to access a sample report https://meditechinsights.com/crispr-technology-market/request-sample/

Growing Investments from Governments, Private Companies, and Venture Capitalists to Drive Market Growth In recent years, fundings and investments in CRISPR technology have been significant, showcasing the growing interest and support for this innovative field. In February 2024, CRISPR Therapeutics secured approximately USD 280 million through an agreement to sell its common shares to a select group of institutional investors. This investment aims to accelerate their gene-editing programs and expand their therapeutic pipeline. Another notable example is the Indian biotechnology start-up CrisprBits, which raised USD 250,000 in pre-seed funding from US-based VJ Group in February 2023. This funding is intended for developing CRISPR-based diagnostics to detect pathogens and antimicrobial resistance genes. Likewise, in July 2023, Pfizer Inc. made a USD 25 million equity investment in Caribou Biosciences, Inc. a leading clinical-stage CRISPR genome-editing biopharmaceutical company. These examples highlight the substantial financial support and confidence in the potential of CRISPR technology.

Precision and Efficiency Associated with CRISPR Technology to Fuel Market Growth Advancements in imaging technology are a major driver of the CRISPR technology market. Innovations such as CRISPR has become the most widely used gene-editing tool in medicine, agriculture, and microbiology due to its precision and efficiency. The growing demand for accurate gene-editing solutions drives market expansion. CRISPR enables targeted DNA modifications with minimal off-target effects, making it ideal for gene therapies. It outperforms other tools in success rates, enhancing its appeal to researchers and developers. Its applications span gene knockouts, insertions, corrections, and regulation in drug discovery, agriculture, and diagnostics. Continuous R&D has improved CRISPR’s specificity and expanded its applications, further fueling its adoption and market growth in gene-editing technologies.

Competitive Landscape Analysis

The global CRISPR technology market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc., CRISPR Therapeutics AG, Genscript Biotech Corporation, Lonza Group, Ltd., PerkinElmer, Inc., Caribou Biosciences, Inc., Hera Biolabs, and Editas Medicine; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get exclusive insights - download your sample report today  https://meditechinsights.com/crispr-technology-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global CRISPR technology market at the regional- and country-level from 2023 to 2030. The report further segments the market based on offering, application, end user.

Market Size & Forecast (2023-2030), By Offering, USD Million

Products

CRISPR Kits & Enzymes

CRISPR Libraries

Other Products

Services

Cell Line Engineering

gRNA Synthesis

Screening and Validation

Other Services

Market Size & Forecast (2023-2030), By Application, USD Million

Biomedical Applications

Agricultural Applications

Other Applications

Market Size & Forecast (2023-2030), By End User, USD Million

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Other End Users

Market Size & Forecast (2023-2030), By Region, USD Million

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Rest of Asia Pacific

Latin America

Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde Associate, Medi-Tech Insights  +32 498 86 80 79  info@meditechinsights.com 

[healthcare-updates-with-sns]

Synthetic Biology Market: Market Trends and Competitive Analysis 2024-2032

The Synthetic Biology Market was valued at USD 13.1 Billion in 2023 and is expected to reach USD 70.73 Billion by 2031, growing at a CAGR of 23.8% over the forecast period 2024–2031. This rapid expansion is fueled by breakthroughs in genome editing, increasing R&D investments, and a surge in demand for sustainable bio-based products across industries such as healthcare, agriculture, and energy.

Market Overview

Synthetic biology is an interdisciplinary field that combines biology, engineering, and computational methods to design and construct new biological parts, systems, or devices. The market is witnessing accelerated growth due to its potential to revolutionize several sectors by enabling the development of novel biofuels, synthetic vaccines, and environmentally friendly manufacturing processes.

Regional Analysis

North America dominates the global synthetic biology market due to strong governmental support, a robust biotech infrastructure, and significant private-sector investments. The United States continues to lead in terms of technology adoption and research initiatives. Europe follows closely, with increasing focus on sustainable development and bioeconomy strategies. The Asia-Pacific region is projected to witness the fastest growth, driven by rapid industrialization, government funding for biotech research, and growing awareness about environmental concerns in countries like China, India, and Japan.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3955

Market Segmentation

By Product

Synthetic DNA

Synthetic Oligonucleotides

Synthetic Genes

Software Tools

Chassis Organisms

Others

By Technology

Gene Synthesis

Genome Engineering

Measurement & Modeling

Cloning & Sequencing

Nanotechnology

Others

By Application

Healthcare

Agriculture

Industrial Applications

Environmental Applications

Key Players

Thermo Fisher Scientific Inc. (GeneArt Gene Synthesis, Invitrogen GeneArt Strings DNA Fragments)

Merck KGaA (Sigma-Aldrich Gene Synthesis, CRISPR Cas9 Nuclease mRNA)

Agilent Technologies Inc. (SureVector Cloning Kits, Custom Oligonucleotide Synthesis)

Danaher Corporation (Integrated DNA Technologies gBlocks Gene Fragments, CRISPR Genome Editing Tools)

Ginkgo Bioworks (Cell Programming Services, Custom Microbe Engineering)

Amyris Inc. (Biofene® (renewable farnesene), Biossance® Skincare Products)

Twist Bioscience (Synthetic Genes, NGS Target Enrichment Solutions)

Codexis Inc. (CodeEvolver® Protein Engineering Platform, High-Performance Enzymes)

GenScript Biotech Corporation (Gene Synthesis Services, CRISPR Gene Editing Tools)

Novozymes A/S (Industrial Enzymes, Microbial Solutions)

Synthetic Genomics Inc. (Biofuel Development, Microbial Genomic Services)

Precigen, Inc. (UltraCAR-T® Therapies, ActoBiotics® Platform)

Poseida Therapeutics (CAR-T Cell Therapies, Gene Engineering Technologies)

Synlogic, Inc. (Synthetic Biotic™ Medicines, SYNB1618 for PKU Treatment)

Synthego Corporation (CRISPRevolution sgRNA, Engineered Cells)

Pivot Bio (PROVEN™ Nitrogen-Producing Microbes, On-Seed Nitrogen Solutions)

Agrivida, Inc. (GRAINZYME® Feed Additives, INergy™ Silage Solutions)

Impossible Foods Inc. (Impossible™ Burger, Plant-Based Sausage)

Insitro (Machine Learning-Based Drug Discovery, Disease Modeling Platforms)

Apeel Sciences (Plant-Based Food Coatings, Shelf-Life Extension Solutions)

Key Points

The market is expected to grow at a CAGR of 23.8% between 2024 and 2031.

Synthetic DNA and gene synthesis remain leading segments in terms of revenue.

North America holds the largest market share, while Asia-Pacific is the fastest-growing region.

Increased funding for synthetic biology startups is fostering innovation and commercialization.

Applications in drug development, personalized medicine, and sustainable agriculture are key drivers.

Technological convergence with AI and machine learning is enhancing research capabilities.

Future Scope

The synthetic biology market is poised for transformative growth as it intersects with next-generation technologies such as artificial intelligence, machine learning, and robotics. These synergies are expected to enhance precision in bioengineering and accelerate the design-build-test-learn cycle. Moreover, with growing environmental concerns and the urgent need for alternatives to petrochemical-based manufacturing, synthetic biology offers promising solutions for creating biodegradable materials and reducing carbon footprints. Continued collaboration between academic institutions, biotech firms, and regulatory bodies will be crucial in realizing the full potential of this field.

Conclusion

The synthetic biology market is entering a golden era of innovation and expansion. As industries worldwide increasingly prioritize sustainability and precision biotechnology, synthetic biology stands out as a key enabler. With strong market fundamentals, robust research backing, and expanding application areas, the market is well-positioned for exponential growth in the coming years.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Cell Viability Assay Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[global-research-report]

Powering Innovation: Market Insights into Biotechnology Reagents and Kits

The global biotechnology reagents & kits market size is expected to reach USD 1,377.2 billion by 2030, expanding at a CAGR of 10.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market include the introduction of novel and advanced products, a rise in investments in the biotechnology sector, and increasing demand for synthetic biology.

Increasing research and development expenditure for life sciences and biotechnology research is expected to drive the market significantly in the coming years. Over the past few decades, the biotechnology sector has witnessed a paradigm shift toward new treatments & drugs, biologically controlled production processes, genetically modified foods, biologically based computing, and new materials, thereby propelling the market growth.

Advancements in molecular diagnostic techniques, such as droplet digital PCR, NGS, and genome-wide sequencing with respect to accuracy, reproducibility, and timeline, have influenced the adoption of biotechnology reagents & kits in the market. The advent of long-read sequencing has made sequencing of longer strands of DNA possible by only reading single DNA molecules, in turn, driving the market growth.

Cell culture technology accounted for the largest revenue share in 2022 owing to the vast product portfolio offered by the key entities and expanding cell biology research. RNA-Seq using NGS technology has emerged as the method of choice for research communities investigating the transcriptome. The virus segment dominated the market in 2020 with increased adoption in cell & gene therapies and vaccinology. The ongoing pandemic has positively impacted the market growth as focused efforts are being conducted for vaccine development using viral vectors.

North America captured the maximum revenue share in 2022 with the U.S. being the largest contributor. The presence of key players coupled with active involvement in research activity has contributed to the maximum share of the region. Asia Pacific is projected to register the fastest CAGR from 2023 to 2030 owing to the improvements in health care infrastructure, entry of large biotechnological organizations, and increasing R&D activities. The key players in the global market are engaged in collaboration with biopharma developers to support their product development process.

Biotechnology Reagents & Kits Market Report Highlights

The detection kits segment accounted for the maximum revenue share in 2022 owing to the high demand due to the pandemic

Amplification kits are anticipated to register a considerable growth rate due to the expanding applications of LAMP technology and PCR

The development of Point-of-Care (POC) testing has primarily driven the market for on-site testing

On-site DNA testing administers a broad array of DNA paternity and family relationship, including forensic DNA testing services and prenatal testing options

Currently, the healthcare segment is the key end-user of the market with the highest penetration of reagents & kits, in terms of usage, in this segment

Curious about the Biotechnology Reagents and Kits Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Biotechnology Reagents & Kits Market Segmentation

Grand View Research has segmented the global biotechnology reagents & kits market based on kit type, technology, tested parameters, purpose, end-use, and region:

Biotechnology Reagents & Kits Kit Type Outlook (Revenue, USD Billion, 2018 - 2030)

Purification Kits

Amplification Kits

Detection Kits

Isolation Kits

Others

Biotechnology Reagents & Kits Technology Outlook (Revenue, USD Billion, 2018 - 2030)

LAMP Technology

PCR

Cell Culture

Sequencing

Chromatography

Electrophoresis

Flow Cytometry

Other Technologies

Biotechnology Reagents & Kits Tested Parameters Outlook (Revenue, USD Billion, 2018 - 2030)

DNA

RNA

Enzymes

Proteins

Others

Biotechnology Reagents & Kits Purpose Outlook (Revenue, USD Billion, 2018 - 2030)

On-site

Laboratory

Biotechnology Reagents & Kits End-use Outlook (Revenue, USD Billion, 2018 - 2030)

Healthcare

Food & Agriculture

Natural Resources & Environment

Industrial Processing

Others

Biotechnology Reagents & Kits Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Players of Biotechnology Reagents & Kits Market

Thermo Fisher Scientific

QIAGEN

New England Biolabs

Illumina, Inc.

Agilent Technologies, Inc.

Bio-Rad Laboratories

Hoffmann-La Roche Ltd.

Merck KGaA

Promega Corp.

Takara Bio, Inc.

LGC Ltd.

Toyobo Co. Ltd.

Order a free sample PDF of the Biotechnology Reagents and Kits Market Intelligence Study, published by Grand View Research.

[fortunatelypsychiceagle]

Europe Synthetic Biology Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2030

The Europe Synthetic Biology Market is a rapidly evolving sector with significant growth potential, driven by advancements in biotechnology, increasing demand for sustainable solutions, and diverse applications across industries. Below is a detailed breakdown of the market segmentation, key trends, and competitive landscape: 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 - https://www.businessmarketinsights.com/sample/BMIRE00025389

Europe Synthetic Biology Market Segmentation

By Product:

Enzymes: Widely used in industrial and medical applications due to their catalytic properties.

Chassis Organisms: Engineered microorganisms used as platforms for synthetic biology applications.

Oligonucleotides: Dominated the market in 2020, driven by their use in diagnostics, therapeutics, and research.

Xeno-Nucleic Acids (XNAs): Emerging segment with potential applications in biotechnology and medicine.

By Technology:

Measurement & Modeling: Essential for understanding and predicting biological systems.

Cloning & Sequencing: Foundational technologies for genetic engineering.

Genome Engineering: Expected to grow at the fastest CAGR, driven by CRISPR and other gene-editing tools.

Gene Synthesis: Dominated the market in 2020, enabling the creation of custom DNA sequences.

Nanotechnology: Increasingly integrated with synthetic biology for advanced applications.

Others: Includes bioinformatics and automation technologies.

By Application:

Medical Applications: Dominated the market in 2020, with growth driven by gene therapies, personalized medicine, and vaccine development.

Industrial Applications: Includes bio-manufacturing of chemicals, materials, and biofuels.

Food and Agriculture: Focused on engineered crops, alternative proteins, and sustainable farming solutions.

Environmental Applications: Includes bioremediation and carbon capture technologies.

Others: Includes research and educational applications.

By Country:

UK: A leading hub for synthetic biology research and innovation.

Germany: Strong industrial base and government support for biotechnology.

France: Growing investments in synthetic biology for healthcare and agriculture.

Italy: Emerging market with increasing R&D activities.

Spain: Focused on environmental and agricultural applications.

Rest of Europe: Includes countries like Switzerland, the Netherlands, and Nordic nations, which are also significant contributors.

Key Trends and Insights

Regulatory Environment:

Europe has stringent regulations for genetically modified organisms (GMOs) and synthetic biology products, which can impact market entry and innovation.

The European Medicines Agency (EMA) and European Food Safety Authority (EFSA) play critical roles in approving synthetic biology-based products.

Consumer Preferences:

Increasing demand for sustainable and eco-friendly products is driving innovation in industrial and environmental applications.

In medical applications, there is a growing preference for personalized and precision medicine.

Economic Conditions:

Western Europe (UK, Germany, France) has well-established biotechnology sectors, while Southern and Eastern Europe are emerging markets with growth potential.

Public and private funding for synthetic biology research is increasing across the region.

Technological Advancements:

CRISPR and other genome-editing tools are revolutionizing the field.

Automation and AI are enhancing the efficiency of synthetic biology workflows.

Underserved Areas:

Eastern Europe and parts of Southern Europe present opportunities for market expansion due to lower competition and growing interest in biotechnology.

Competitive Landscape

The Europe synthetic biology market is highly competitive, with key players including:

Agilent Technologies, Inc.

Amyris

Codexis

Genscript Biotech Corporation

Integrated DNA Technologies

Merck KGaA

New England Biolabs

Novozymes A/S

Thermo Fisher Scientific

Twist Bioscience

These companies are focusing on strategic initiatives such as partnerships, acquisitions, and R&D investments to strengthen their market position. For example:

Twist Bioscience is a leader in gene synthesis and DNA data storage.

Novozymes focuses on industrial enzymes and sustainable solutions.

Merck KGaA is expanding its portfolio in genome engineering and gene synthesis.

Growth Drivers

Increasing Demand for Personalized Medicine:

Synthetic biology enables the development of tailored therapies, driving growth in the medical applications segment.

Sustainability Initiatives:

Synthetic biology offers solutions for bio-based materials, renewable energy, and waste reduction, aligning with Europe’s Green Deal objectives.

Technological Innovations:

Advances in gene editing, automation, and AI are accelerating research and commercialization.

Government Support:

Funding programs and initiatives, such as Horizon Europe, are boosting synthetic biology research and innovation.

Challenges

Regulatory Hurdles:

Strict GMO regulations can slow down the approval and commercialization of synthetic biology products.

Public Perception:

Concerns about the ethical and environmental implications of synthetic biology may hinder market growth.

High R&D Costs:

Developing synthetic biology products requires significant investment, which can be a barrier for smaller companies.

Conclusion

The Europe synthetic biology market is poised for significant growth, driven by technological advancements, increasing demand for sustainable solutions, and diverse applications across industries. Companies that can navigate regulatory challenges, adapt to local market conditions, and leverage emerging technologies will be well-positioned to capitalize on the opportunities in this dynamic market.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio: Snehal Senior Market Research Expert at Business Market InsightsBrowse more Reports Europe Frozen Fruits Size -https://businessmarketins02.blogspot.com/2025/02/europe-frozen-fruits-size-share.html   Europe Power over Ethernet Market - https://businessmarketins02.blogspot.com/2025/02/europe-power-over-ethernet-market-size.html US Sleepwear Market - https://businessmarketins02.blogspot.com/2025/02/us-sleepwear-market-size-share-trends.html

[industrynewsupdates]

A Deep Dive into the Molecular Biology Enzymes, Reagents And Kits Market: Insights and Analysis

The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 44.67 billion by 2030, registering a CAGR of 9.65%, according to a new report by Grand View Research, Inc The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

Gather more insights about the market drivers, restrains and growth of the Molecular Biology Enzymes, Reagents And Kits Market

Molecular Biology Enzymes, Reagents, and Kits Market Report Highlights

• By product, the kits and reagents held the largest share in 2022. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth

• By application, sequencing accounted for the largest share in 2022 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth

• By end-use, the pharma and biotech segment held the largest share in 2022. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth

• North America held the largest revenue share in 2022. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

Molecular Biology Enzymes, Reagents, and Kits Market Segmentation

Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market based on product, application, end-use, and region:

Molecular Biology Enzymes, Reagents, and Kits Product Outlook (Revenue, USD Million, 2018 - 2030)

• Kits & Reagents

• Enzymes

Molecular Biology Enzymes, Reagents, and Kits Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cloning

• Sequencing

• PCR

• Epigenetics

• Restriction Digestion

• Other Applications

Molecular Biology Enzymes, Reagents, and Kits End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma & Biotech

• Academic & Research

• Hospital & Diagnostics

• Others

Molecular Biology Enzymes, Reagents, and Kits Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

List of Key Players in Molecular Biology Enzymes, Reagents, and Kits Market

• Thermo Fisher Scientific, Inc.

• Illumina, Inc.

• Agilent Technologies, Inc.

• QIAGEN

• Promega Corporation

• New England Biolabs

• Merck KGaA

• F. Hoffmann-La Roche Ltd.

• Bio-Rad Laboratories, Inc.

• Takara Bio, Inc.

• LGC Limited

Order a free sample PDF of the Molecular Biology Enzymes, Reagents And Kits Market Intelligence Study, published by Grand View Research.

[industryforecastnews]

Synthetic Biology Market Size, Share And Trends Report, 2030

Synthetic Biology Market Growth & Trends

The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/synthetic-biology-market

Synthetic Biology Market Report Highlights

By technology, the PCR segment held the largest share of the market. This is attributed to the accelerated development in modern life science, with PCR technology being widely employed in numerous fields of medical research, virus detection, and the food & beverage industry

The genome-editing segment is expected to grow steadily during the forecast period. It enables researchers to modify the DNA of various organisms, including plants, bacteria, and animals, and their demand is expected to skyrocket in the coming years

By product, Oligonucleotide and Synthetic DNA is anticipated to have the larger market share in 2030. The falling price of synthesis and increasing requirement for synthetic DNA, RNA, and genes that are employed in numerous applications contribute to the segment growth

By application, the healthcare segment held a larger global market share. This is attributed to an increase in drug screening and discovery. Moreover, the use of synthetic biology can reduce the cost of drug discovery and propel market growth

By end-user, the biotechnology and pharmaceutical companies segment held a larger share in 2024, owing to the growing availability of modern research facilities, favorable legislation, and government assistance and funding

North America was positioned as the dominant market in 2024 due to the presence of high R&D investment, the availability of technologically advanced healthcare research frameworks, and the development of the synthetic biology market in the region

The Asia Pacific is expected to witness considerable growth in the future owing to the rising development of personalized treatment and the presence of key players

Synthetic Biology Market Segmentation

Grand View Research has segmented the global synthetic biology market based on product, technology, application, end use, and region

Synthetic Biology Product Outlook (Revenue, USD Million, 2018 - 2030)

Oligonucleotide/Oligo Pools and Synthetic DNA

Enzymes

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

Synthetic Biology Technology Outlook (Revenue, USD Million, 2018 - 2030)

NGS Technology

PCR Technology

Genome Editing Technology

Bioprocessing Technology

Other Technologies

Synthetic Biology Application Outlook (Revenue, USD Million, 2018 - 2030)

Healthcare

Non-healthcare

Synthetic Biology End Use Outlook (Revenue, USD Million, 2018 - 2030)

Biotechnology and Pharmaceutical companies

Academic and Research Institutes

Others

Synthetic Biology Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

List of Key Players of Synthetic Biology Market

Bota Biosciences Inc.

Codexis, Inc.

Creative Biogene.

Creative Enzymes.

Enbiotix, Inc.

Illumina, Inc.

Merck Kgaa (Sigma-Aldrich Co. Llc)

New England Biolabs

Eurofins Scientific

Novozymes

Pareto Bio, Inc.

Scarab Genomics, Llc

Synthego

Synthetic Genomics Inc.

Thermo Fisher Scientific, Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/synthetic-biology-market

[tamanna31]

New Trends of Oligonucleotide Synthesis Market with Industry Analysis by 2024 – 2030

Oligonucleotide Synthesis Industry Overview

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

·         Thermo Fisher Scientific, Inc.

·         Merck KGaA

·         Danaher Corporation

·         Dharmacon Inc.

·         Agilent Technologies

·         Bio-synthesis

·         Kaneka Eurogentec S.A

·         LGC Biosearch Technologies

·         Biolegio

·         Twist Bioscience

Recent Developments

In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[tushar38]

Molecular Cloning Kits Market: Growth Factors and Challenges

Introduction to Molecular Cloning Kits Market

The Molecular Cloning Kits Market is experiencing robust growth, driven by the rising demand for genetic research and advancements in molecular biology. These kits, essential tools for gene cloning and recombinant DNA technology, are widely used in academic research, biotechnology, and pharmaceutical industries. With increasing investments in life sciences and the surge in personalized medicine, the market is poised for significant expansion. Additionally, technological innovations, such as automation and high-throughput capabilities, are enhancing the efficiency and accuracy of molecular cloning processes, further fueling market growth.Market overview

The Molecular Cloning Kits Market is Valued USD 431.84 Million in 2024 and projected to reach USD 1,250.25 Million by 2030, growing at a CAGR of CAGR of 16.4% During the Forecast period of 2024-2032.. The market is driven by advancements in synthetic biology, personalized medicine, and the demand for efficient cloning methods. Companies are focusing on developing user-friendly, high-precision kits to cater to the diverse needs of researchers and clinicians. Furthermore, the expansion of academic research, coupled with government funding, supports the market's upward trajectory.

Access Full Report :https://www.marketdigits.com/checkout/3824?lic=s

Major Classifications are as follows:

By Application

Gene Expression

Gene Editing

Functional Analysis

Genome Engineering

Diagnostics and Therapeutics

By End-user

Academic & Research Institutions

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Contract Research Organizations

Industrial Biotechnology Companies

Major players in Molecular Cloning Kits Market:

Thermo Fisher Scientific, Inc., Merck KGaA (Sigma-Aldrich), New England Biolabs, Inc, Agilent Technologies, Inc, Qiagen N.V., Takara Bio Inc., Promega Corporation, Illumina, Inc, Clontech Laboratories (a Takara Bio Company), Bio-Rad Laboratories, Inc., and Others

Market Drivers in Molecular Cloning Kits Market

Advancements in Genetic Research: Ongoing innovations in genetic engineering, such as CRISPR-Cas9, gene editing, and synthetic biology, have increased the demand for reliable and efficient molecular cloning kits. These advancements enable more precise and rapid DNA manipulation, making cloning kits essential tools for modern molecular biology labs.

Rising Demand for Personalized Medicine: Personalized medicine relies heavily on genetic analysis and modifications, driving the need for molecular cloning technologies. The ability to clone specific genes or sequences is crucial for developing targeted therapies and diagnostics tailored to individual genetic profiles.

Growth in Biopharmaceutical and Biotechnology Sectors: The expanding biopharmaceutical industry is a major driver, as molecular cloning is integral to the production of recombinant proteins, monoclonal antibodies, and other biologic drugs. Increased R&D investments in these sectors are boosting the demand for cloning kits.

Market Challenges in Molecular Cloning Kits Market

High Costs of Advanced Cloning Technologies: The cost of molecular cloning kits, especially those featuring advanced technologies such as high-fidelity enzymes and complex vectors, can be prohibitively expensive for smaller labs and academic institutions with limited budgets. These costs can limit the adoption of state-of-the-art cloning solutions, particularly in developing regions.

Complexity of Cloning Procedures: Molecular cloning can be a technically demanding process that requires expertise in genetic manipulation and a deep understanding of the underlying biological systems. The complexity of the procedures can pose a barrier to entry for new users and may lead to variability in results, affecting the reproducibility and reliability of experiments.

Regulatory and Ethical Concerns: The regulatory landscape for genetic research, including cloning, is complex and varies significantly across regions. Ethical concerns regarding genetic manipulation, particularly in the context of human and animal genetics, can lead to stringent regulations and restrictions that impact market growth. Navigating these regulatory environments can be challenging for companies operating in this space.

Market Opportunities of Molecular Cloning Kits Market

Expansion in Emerging Markets: Rapid advancements in research infrastructure in emerging economies, such as China, India, and Brazil, present significant opportunities for market expansion. Increased investments in biotechnology and life sciences in these regions, supported by government initiatives, create a conducive environment for the adoption of molecular cloning technologies.

Rising Demand in Synthetic Biology and Gene Therapy: The growing fields of synthetic biology and gene therapy provide substantial growth opportunities for molecular cloning kits. As researchers develop novel therapies and synthetic organisms, the demand for precise and efficient cloning solutions will rise, fueling the market's growth.

Development of Automated and High-Throughput Cloning Systems: The trend towards automation and high-throughput technologies in molecular biology offers a significant opportunity for cloning kit manufacturers. Automated systems reduce labor intensity, minimize errors, and increase the efficiency of cloning processes, making them attractive to both research institutions and commercial labs.

Conclusion:

The Molecular Cloning Kits Market is positioned for continued growth, underpinned by technological innovations and expanding research applications in various fields, including healthcare, agriculture, and environmental sciences. While the market faces challenges like high costs and regulatory hurdles, the rising demand for efficient and accurate cloning methods provides ample opportunities for growth. As the landscape of molecular biology evolves, the development of advanced, user-friendly cloning kits will be critical in addressing the needs of researchers and clinicians worldwid

[trendtrackershq]

𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.nextmsc.com/synthetic-biology-market/request-sample

In a world where innovation is the key to solving complex global challenges, the 𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 is emerging as a game-changer. With the power to design and engineer biological systems for new functions, this field is revolutionizing industries ranging from healthcare to agriculture and energy.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡: The Synthetic Biology Market is poised for exponential growth, driven by advancements in gene editing, bioengineering, and AI. The potential applications are vast, from sustainable biofuels to groundbreaking medical therapies.

𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: As we look to the future, synthetic biology offers solutions to some of the most pressing issues of our time—climate change, food security, and personalized medicine. By harnessing nature's building blocks, we're creating a more sustainable and innovative world.

𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐭𝐨 𝐖𝐚𝐭𝐜𝐡:

𝐂𝐑𝐈𝐒𝐏𝐑 𝐚𝐧𝐝 𝐆𝐞𝐧𝐞 𝐄𝐝𝐢𝐭𝐢𝐧𝐠: Precision in modifying genetic material is opening new doors.

𝐁𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠: A sustainable approach to producing chemicals, materials, and fuels.

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Personalized treatments and vaccines that adapt to individual needs.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Thermo Fisher Scientific Inc. 

Merck KGaA

Agilent Technologies Inc. 

Novozymes A/S

Ginkgo Bioworks, 

Amyris, Inc. 

Precigen, Inc.

GenScript Biotech Corporation 

Twist Bioscience

Synthetic Genomics Inc.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.nextmsc.com/report/synthetic-biology-market

𝐓𝐡𝐞 𝐈𝐦𝐩𝐚𝐜𝐭: This is not just a trend; it's a transformative shift that will redefine industries and improve lives globally. The Synthetic Biology Market is where science meets innovation, and the possibilities are endless.

[creativecontentcraze]

Rising Demand For Pharmaceutical Excipients To Boost Microcrystalline Cellulose Market Growth

The global microcrystalline cellulose market is estimated to be valued at US$ 1349.84 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Microcrystalline cellulose is a partially depolymerized cellulose prepared by treating alpha cellulose, obtained as a pulp from fibrous plant materials, with mineral acids. It is commonly used as a diluent, binder, suspension agent and thickening agent in pharmaceutical formulations as well as in food & beverage industries. Microcrystalline cellulose provides advantages such as better flow properties, low density, excellent binding properties, good compaction characteristics and high compatibility with other excipients. The use of microcrystalline cellulose in pharmaceutical excipients is growing owing to increasing demand for tablets and capsules globally which will drive the market during forecast period. Key Takeaways - Key players operating in the microcrystalline cellulose market are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio, Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG, Hamilton Company, ZS Genetics, Inc. LI-COR, Inc. - Growing demand for pharmaceutical excipients from the pharmaceutical industry is one of the major factors driving the growth of the microcrystalline cellulose market. Tablets and capsules are the most commonly used dosage forms across the globe which requires excipients like microcrystalline cellulose in large quantities. - Technological advancements in microcrystalline cellulose production methods helps in improving product attributes such as flowability, compressibility, diluent properties etc. Continuous innovations in particle engineering techniques helps manufacturers develop application-specific microcrystalline cellulose grades. Market Trends - Growing preference for plant-based excipients: Regulatory authorities are promoting use of plant-based excipients over synthetic ones. This drives demand for naturally-sourced microcrystalline cellulose. - Development of multifunctional microcrystalline cellulose market grades: Manufacturers are developing microcrystalline cellulose with additional properties like disintegration, binder etc. to simplify formulation design. Market Opportunities - Emerging markets in Asia Pacific and Middle East & Africa: Growth in pharmaceutical manufacturing in these regions owing to low production cost and increasing demand offer opportunities for microcrystalline cellulose suppliers. - Alternative applications: Microcrystalline cellulose finds increasing usage in non-pharmaceutical applications like food, paints, coatings industries due to its functional properties. Impact of COVID-19 on Microcrystalline Cellulose Market The outbreak of the COVID-19 pandemic has significantly impacted the growth of the microcrystalline cellulose market. The imposition of nationwide lockdowns led to the temporary closure of manufacturing facilities across major regions like North America, Europe, and Asia Pacific. This disrupted supply chains and reduced the procurement of raw materials required for the production of microcrystalline cellulose. With restrictions on travel and transportation, the logistics and delivery of finished products were also interrupted. The pandemic also caused a decline in consumer spending on non-essential items like processed foods and pharmaceuticals where microcrystalline cellulose finds widespread applications. This restrained the demand from end-use industries in the initial months of the pandemic.

In terms of value, the North American region accounted for the major share of the global microcrystalline cellulose market in 2024. This can be attributed to growing healthcare expenditure and high consumption of processed and packaged foods where microcrystalline cellulose finds widespread application as an additive, binder, disintegrant, and stabilizer. The growing prevalence of lifestyle diseases coupled with an aging population has stimulated the regional demand for pharmaceuticals over the years and boosted microcrystalline cellulose procurement. Further, the presence of leading pharmaceutical companies in countries like the US and Canada also drives market growth through increased outsourcing of microcrystalline cellulose production.

Get More Insights On, Microcrystalline Cellulose Market

About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[researchanalysts]

Whole Genome Synthesis Market: Unlocking the Potential of Synthetic Biology for Research and Industrial Applications

The Whole Genome Synthesis Market is Valued at USD 2.4 billion in 2019 and projected to reach USD 13.03 billion by 2027, growing at a CAGR of 26% During the Forecast period of 2024–2032.

Introduction: Whole Genome Synthesis represents a revolutionary advancement in synthetic biology, enabling the construction of entire genomes from scratch. This technology allows for the creation of customized organisms with tailored genetic traits, opening new frontiers in research, medicine, agriculture, and biotechnology. By synthesizing DNA sequences de novo, scientists can design organisms to produce biofuels, pharmaceuticals, and other valuable compounds, thereby accelerating innovation across multiple industries.

Download a Free Sample Copy of the Report: https://www.marketdigits.com/request/sample/274

Key Manufacturers: ➢ J. Craig Venter Institute,  ➢ Ansa Biotechnologies,  ➢ Twist Bioscience,  ➢ Integrated DNA Technologies,  ➢ Thermo Genewiz Eurofins Scientific,  ➢ Quintara Biosciences, ATD Bio Ltd.,  ➢ Fisher Scientific, Inc.,  ➢ OriGene Technologies, Inc,  ➢ Bioneer Corporation,  ➢ Atum,  ➢ Icon Genetics

Why Should Access to This Report? Access to this comprehensive report on the Whole Genome Synthesis Market is crucial for stakeholders, researchers, and industry leaders aiming to stay ahead in this rapidly evolving field. The report provides in-depth insights into market trends, technological advancements, and key players driving the market. It also highlights potential challenges and opportunities, offering a strategic roadmap for investment and development. By understanding the current landscape and future projections, stakeholders can make informed decisions and leverage emerging opportunities in synthetic biology.

Inquire Before Buying at — https://www.marketdigits.com/request/enquiry-before-buying/274

Major Classifications are as follows:

By Application ➲ Chemical & Specialty Chemical ➲ Biotechnology ➲ Pharmaceutical ➲ Farming Sector

By Region ➲ North America ➲ Europe ➲ Middle East and Africa (MEA) ➲ Asia-Pacific (APAC)

The objective of this study is to identify the market opportunities and estimate market size by segments and countries for the last few years and to forecast the values for the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis of the market, by incorporating complete pricing and cost analysis of components & products, Porter’s analysis, and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field.

Click to Request Free 10% Customization on this Report @ https://www.marketdigits.com/request/customization/274

Reason to Purchase this Report:

✤ Determine prospective investment areas based on a detailed trend analysis of the global market over the next years. ✤ Gain an in-depth understanding of the underlying factors driving demand for different market segments in the top spending countries across the world and identify the opportunities offered by each of them. ✤ Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others. ✤ Identify the major channels that are driving the global market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion. ✤ Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global market. ✤ Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top market providers around the world which include information about their products, alliances, recent contract wins, and financial analysis wherever available.

Conclusion: The Whole Genome Synthesis Market is poised for significant growth, driven by advancements in synthetic biology and increasing demand for genetically engineered organisms. 

This report provides a comprehensive analysis of the market, offering valuable insights for stakeholders to navigate the complexities and seize opportunities in this dynamic field. By leveraging the information presented, businesses and researchers can drive innovation, enhance productivity, and contribute to the development of cutting-edge biotechnological solutions.

Request for Discount @ https://www.marketdigits.com/request/discount/274

[bhushans]

The Rise of Tech-Driven Therapies: Reshaping the Global Synthetic Biology Market

The global Synthetic Biology market is set for exponential growth, with an expected increase from USD 3.75 billion in 2024 to a staggering USD 31.73 billion by 2034. This impressive expansion corresponds to a compound annual growth rate (CAGR) of 23.8% over the forecast period.

The surge in the synthetic biology market is driven by the rising need to enhance practical capabilities, redesign naturally occurring systems, and develop new biological components, tools, and systems. These advancements are paving the way for innovative applications across various industries, including healthcare, agriculture, and environmental management.

Request Your Detailed Report Sample With Your Work Email: https://www.futuremarketinsights.com/reports/sample/rep-gb-1226

Its rapid expansion is being driven by the revolution that synthetic biology is bringing to numerous businesses and tackling pressing global concerns. The market is driven by its ability to revolutionize industries and provide cutting-edge answers to urgent problems.

Key Takeaways:

The synthetic biology market is projected to surge from US$3.75 billion in 2024 to US$31.73 billion by 2034, reflecting a remarkable CAGR of 23.8%.

Rising demand for enhanced functionalities, redesigned natural systems, and novel biological tools are fueling market growth.

Synthetic biology holds immense potential in addressing critical challenges related to bio-based chemicals, renewable fuels, and affordable medications.

The need for genetically modified crops to ensure global food security is further propelling advancements in the field.

The convergence of technological breakthroughs and growing market needs positions synthetic biology as a key solution provider for social and environmental concerns, fostering further innovation in the coming years.

Demand for sustainable solutions: Businesses and consumers alike are looking for more environmentally friendly options. The field of synthetic biology has promise for the development of bio-based compounds, renewable fuels, and more reasonably priced pharmaceuticals and vaccinations. Synthetic biology solutions are becoming increasingly in demand as a result of this move towards sustainable practices. Concerns about food security: To maintain food security in the face of an increasing global population, creative solutions are required. Developments in synthetic biology are essential to the creation of genetically engineered crops with increased resistance and yields. The potential for this technology to alleviate the world’s food shortages is enormous.

Recent Developments in the Synthetic Biology Industry

In January 2024, Rice University established the Rice Synthetic Biology Institute (RSBI) in Texas to promote collaborative research in synthetic biology and convert it into beneficial technologies. The institute aims to attract global attention to Rice’s esteemed synthetic biology program and retain top talent.

In January 2024, Kerstin Göpfrich founded a research group at the Max Planck Institute for Medical Research in Heidelberg, Germany. The group focuses on engineering life and exploring new cell abilities to create new life forms.

In November 2023, the United Kingdom-based team led by Ben Blount at the University of Nottingham developed a yeast strain with over 50% synthetic DNA, a significant achievement in the Saccharomyces cerevisiae (Sc) 2.0 project, a global effort to produce synthetic versions of the yeast genome.

In July 2023, WPI researchers Eric Young and Kevin Keating developed a method to express genes across bacterial species by designing a generalized collection of DNA parts that can be used with multiple species to assemble DNA sequences.

Key Companies in the Synthetic Biology Market:

Thermo Fisher Scientific, Inc.

Merck KGaA

Novozymes

Agilent Technologies, Inc.

Codexis, Inc.

Bota Biosciences Inc.

Creative Biogene.

Creative Enzymes.

Enbiotix, Inc.

Illumina, Inc.

Eurofins Scientific

New England Biolabs

Pareto Bio, Inc.

Scarab Genomics, Llc

Synthego

Twist Bioscience

Synthetic Genomics Inc.

BioBricks Foundation

DIYbio

Amyris

Cyrus Biotechnology

TeselaGen

Key Segments:

By Product:

Oligonucleotides

Enzymes

Synthetic Cells

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

By Application:

Healthcare

Non-Healthcare

By End User:

Biopharmaceutical manufacturers

Academic and Government Research Institutes

Others

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

[healthcare-updates-with-sns]

DNA Synthesizer Market: Global Trends and Forecast 2024-2032

The DNA Synthesizer Market was valued at USD 305.32 million in 2023 and is expected to reach USD 769.57 million by 2031, growing at a compound annual growth rate (CAGR) of 12.3% during the forecast period 2024–2031.

A DNA synthesizer enables the production of specific DNA sequences through a chemical process, playing a vital role in modern biology and biotechnology applications. Increasing advancements in synthetic biology, demand for personalized medicine, and widespread applications in diagnostics and therapeutics are key drivers accelerating market growth. The integration of automation and AI in synthesizer systems further enhances efficiency and accuracy, making these tools essential in research and commercial settings.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3946

Market Segmentation

By Product Type:

Instruments

Reagents

Software & Services

By Application:

Research & Development

Diagnostics

Therapeutics

Agriculture

By End User:

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Contract Research Organizations (CROs)

Regional Analysis

North America dominates the market due to the presence of leading biotech companies, advanced research infrastructure, and significant investment in genomics.

Europe is experiencing steady growth driven by expanding research initiatives and government support.

Asia-Pacific is projected to witness the fastest growth, particularly in China, India, and Japan, due to rising healthcare awareness, investments in biotechnology, and expanding R&D activities.

Latin America, the Middle East, and Africa show emerging opportunities with growing adoption of genetic technologies and increasing healthcare expenditure.

Key Players

Danaher - Applied Biosystems DNA Synthesizers

Twist Bioscience - Twist Bioscience DNA Synthesis Platform

Kilobase - Kilobase DNA Synthesizer

LGC Limited - LGC Biosearch Technologies Custom DNA Synthesis

CSBio - CSBio DNA Synthesizers

K&A Labs GmbH - K&A DNA Synthesizers

DNA Script - DNA Script Synteza

OligoMaker ApS - OligoMaker DNA Synthesizers

PolyGen GmbH - PolyGen DNA Synthesizers

Biolytic Lab Performance Inc. - Biolytic DNA Synthesizers

Key Highlights

The market is expected to grow at a CAGR of 12.3% from 2024 to 2031.

Technological innovations in gene synthesis are revolutionizing DNA manufacturing processes.

Reagents hold a significant share due to recurring usage in synthesis protocols.

Increasing collaborations among academic institutions and biotech firms are fueling market expansion.

Rapidly growing demand in synthetic biology, gene editing, and CRISPR applications.

Automation in DNA synthesizers is enhancing throughput and scalability.

Future Outlook

The DNA Synthesizer Market is poised for transformative growth over the coming years. With continued progress in synthetic biology, the expansion of CRISPR and gene editing technologies, and increasing investment in precision medicine, demand for high-performance DNA synthesizers is expected to surge. Emerging markets and technological integration such as AI and robotics in synthesis platforms are likely to open new frontiers, making these tools even more accessible and efficient for researchers and commercial users alike.

Conclusion

The global DNA Synthesizer Market is evolving rapidly, driven by innovation, demand for custom genetic solutions, and growing applications across diverse sectors. As technologies become more streamlined and accessible, the market will continue to offer significant opportunities for industry players, researchers, and healthcare providers worldwide.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Cell Viability Assay Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[global-research-report]

The Future of Gene Synthesis: Market Analysis and Key Insights

The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due  to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.

The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.

Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.

Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.

Gene Synthesis Market Report Highlights

The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology

By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes

By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment

By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies

By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs

North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region

Gene Synthesis Market Segmentation

Grand View Research has segmented the global gene synthesis market report based on the method, services, application, end-use, and region:

Gene Synthesis Method Outlook (Revenue, USD Million, 2018 - 2030)

Solid-phase Synthesis

Chip-based Synthesis

PCR-based Enzyme Synthesis

Gene Synthesis Services Outlook (Revenue, USD Million, 2018 - 2030)

Antibody DNA Synthesis

Viral DNA Synthesis

Others

Gene Synthesis Application Outlook (Revenue, USD Million, 2018 - 2030)

Gene & Cell Therapy Development

Vaccine Development

Disease Diagnosis

Others

Gene Synthesis End-use Outlook (Revenue, USD Million, 2018 - 2030)

Biotechnology & Pharmaceutical Companies

Academic & Government Research Institutes

Contract Research Organizations

Gene Synthesis Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

India

Japan

South Korea

Australia

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Players

GenScript

Brooks Automation, Inc. (GENEWIZ)

Boster Biological Technology

Twist Bioscience

ProteoGenix, Inc

Biomatik

ProMab Biotechnologies, Inc.

Thermo Fisher Scientific, Inc.

Integrated DNA Technologies, Inc.

OriGene Technologies, Inc.

Order a free sample PDF of the Gene Synthesis Market Intelligence Study, published by Grand View Research.

[simranmakhija1]

Regulatory Considerations in the DNA and Gene Cloning Services Market

The DNA and Gene Cloning Services Market is experiencing significant growth driven by the increasing demand for custom DNA constructs, genetically engineered organisms, and gene editing services in various fields, including biotechnology, pharmaceuticals, agriculture, and research. Gene cloning, the process of replicating and amplifying specific DNA sequences, plays a crucial role in molecular biology research, drug discovery, and biomanufacturing.

Get a free Sample: https://www.marketdigits.com/request/sample/3785 

One of the primary drivers of market growth is the expanding applications of gene cloning and genetic engineering in biopharmaceutical production. Recombinant DNA technology allows for the production of therapeutic proteins, antibodies, vaccines, and gene therapies, offering potential treatments for a wide range of diseases, including cancer, genetic disorders, and infectious diseases. As a result, pharmaceutical companies and biotech firms are increasingly outsourcing gene cloning services to specialized providers to expedite their drug development pipelines and reduce time-to-market.

Furthermore, advancements in gene editing technologies, such as CRISPR-Cas9, TALENs, and zinc finger nucleases, have revolutionized the field of genetic engineering, enabling precise modifications of DNA sequences in various organisms. Gene editing services, including gene knockout, knock-in, and point mutation, are in high demand for applications such as functional genomics, cell line engineering, and agricultural biotechnology. Additionally, the emergence of synthetic biology and genome editing platforms has created new opportunities for engineering custom DNA constructs and genetic circuits for biomanufacturing and biotechnology applications.

The DNA and Gene Cloning Services Market is Valued USD 3.02 billion in 2024 and projected to reach USD 7.84 billion by 2030, growing at a CAGR of CAGR of 14.6% During the Forecast period of 2024-2032.

The DNA and gene cloning services market is characterized by the presence of specialized providers offering a wide range of services, including gene synthesis, gene cloning, gene editing, plasmid preparation, and DNA sequencing. Major players in the market include Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Inc. (IDT), and OriGene Technologies, Inc., among others. These companies provide end-to-end solutions for DNA manipulation, from design and synthesis to cloning and validation, catering to the diverse needs of academic research labs, biotech startups, and pharmaceutical companies worldwide.

Major vendors in the global DNA and Gene Cloning Services Market are Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience and Others

Emerging trends in the DNA and gene cloning services market include the development of high-throughput cloning platforms, automation technologies, and cloud-based bioinformatics tools for DNA design and analysis. These advancements enable researchers to streamline the gene cloning process, reduce experimental variability, and accelerate scientific discovery. Additionally, there is growing interest in gene synthesis and DNA assembly methods that enable the construction of large, complex DNA sequences, such as gene clusters, pathways, and synthetic genomes, for applications in synthetic biology and metabolic engineering.

Looking ahead, the DNA and gene cloning services market is poised for continued growth driven by advancements in genomics, gene editing, and biomanufacturing technologies. As the demand for custom DNA constructs and genetically engineered organisms continues to rise, specialized service providers will play a critical role in supporting research, drug development, and biotechnology innovation. Collaborations between industry stakeholders, academic institutions, and regulatory agencies will be essential in addressing technical challenges, ensuring quality standards, and facilitating the translation of genetic engineering advancements into real-world applications.

[electronalytics]

Synthetic Biology Market Analysis, Outlook & Forecast till 2033

Synthetic Biology Market was valued at USD 15.47 billion in 2023 to USD 78.51 billion in 2033,  and is expected to expand at a compound annual growth rate (CAGR) of 18.97% from 2024 to 2033.

Introduction:

The Synthetic Biology Market is a rapidly growing field focused on the design and engineering of biological systems. It utilizes principles from engineering, computer science, and molecular biology to create new or modify existing biological components and functions. This market caters to a wide range of applications across various industries.

Definition:

Synthetic biology involves the manipulation of genetic components like DNA and RNA to create novel biological systems or reprogram existing ones for specific purposes. It allows scientists to design and build cells with specific functionalities, unlike traditional genetic modification which primarily focuses on altering single genes.

Market Trends:

Several key trends are driving the Synthetic Biology Market:

Personalized Medicine: Synthetic biology holds immense potential for developing personalized medicine therapies by engineering cells to target specific diseases or create customized treatments.

Biomanufacturing: This market is witnessing a surge in the use of synthetic biology to engineer organisms for the efficient production of valuable bioproducts like pharmaceuticals, biofuels, and biomaterials.

Agriculture: Synthetic biology offers solutions for improving crop yields, enhancing pest resistance, and developing stress-tolerant crops.

Environmental Applications: This field holds promise for bioremediation, creating microbes to clean up pollutants, and developing biofuels as a sustainable energy source.

Objectives of the Market:

Developing Novel Products & Processes: The primary objective is to leverage the power of synthetic biology to create new products and processes in various industries.

Optimizing Existing Biological Systems: This market aims to improve the efficiency and functionality of existing biological systems through targeted engineering.

Addressing Global Challenges: Synthetic biology holds the potential to address global challenges like food security, energy production, and environmental sustainability.

Market Scope:

The Synthetic Biology Market can be segmented based on various factors:

Technology: DNA synthesis, gene editing, metabolic engineering

Application: Personalized medicine, biomanufacturing, agriculture, environmental applications

Product Type: Enzymes, microorganisms, biomaterials

End-Use Industry: Pharmaceuticals, chemicals, agriculture, energy, environmental services

Geographic Region: North America, Europe, Asia Pacific, etc.

Understanding these segments helps market players identify potential opportunities and develop targeted solutions.

Conclusion:

The Synthetic Biology Market is at the forefront of scientific advancement with the potential to revolutionize various industries. As research and development progress, and ethical considerations are addressed, this market is expected to witness significant growth and contribute to solving global challenges in healthcare, agriculture, and environmental sustainability.

Receive the FREE Sample Report of Synthetic Biology Market Research Insights @ https://stringentdatalytics.com/sample-request/synthetic-biology-market/13380/

Market Segmentations:

Global Synthetic Biology Market: By Company • Bota Biosciences Inc. • Codexis, Inc. • Creative Biogene. • Creative Enzymes. • Enbiotix, Inc. • Illumina, Inc. • Merck Kgaa (Sigma-Aldrich Co. Llc) • New England Biolabs • Euro fins Scientific • Novozymes • Pareto Bio, Inc. • Scarab Genomics, Llc • Synthego • Synthetic Genomics Inc. • Thermo Fisher Scientific, Inc. Global Synthetic Biology Market: By Type • Synthetic DNA • Synthetic Oligos • Synthetic Genes • Software Tools • Chassis Organisms • Synthetic Clones • Synthetic Cells Global Synthetic Biology Market: By Application • Pharmaceuticals & Diagnostics • Chemicals • Biofuels • Bioplastics • Others (Environment, Agriculture & Aquaculture)

Regional Analysis of Global Synthetic Biology Market

All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Synthetic Biology market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Click to Purchase Synthetic Biology Market Research Report @ https://stringentdatalytics.com/purchase/synthetic-biology-market/13380/?license=single

Key Report Highlights:

Key Market Participants: The report delves into the major stakeholders in the market, encompassing market players, suppliers of raw materials and equipment, end-users, traders, distributors, and more.

Comprehensive Company Profiles: Detailed company profiles are provided, offering insights into various aspects including production capacity, pricing, revenue, costs, gross margin, sales volume, sales revenue, consumption patterns, growth rates, import-export dynamics, supply chains, future strategic plans, and technological advancements. This comprehensive analysis draws from a dataset spanning 12 years and includes forecasts.

Market Growth Drivers: The report extensively examines the factors contributing to market growth, with a specific focus on elucidating the diverse categories of end-users within the market.

Data Segmentation: The data and information are presented in a structured manner, allowing for easy access by market player, geographical region, product type, application, and more. Furthermore, the report can be tailored to accommodate specific research requirements.

SWOT Analysis: A SWOT analysis of the market is included, offering an insightful evaluation of its Strengths, Weaknesses, Opportunities, and Threats.

Expert Insights: Concluding the report, it features insights and opinions from industry experts, providing valuable perspectives on the market landscape.

Report includes Competitor's Landscape:

➊ Major trends and growth projections by region and country ➋ Key winning strategies followed by the competitors ➌ Who are the key competitors in this industry? ➍ What shall be the potential of this industry over the forecast tenure? ➎ What are the factors propelling the demand for the Synthetic Biology? ➏ What are the opportunities that shall aid in significant proliferation of the market growth? ➐ What are the regional and country wise regulations that shall either hamper or boost the demand for Synthetic Biology? ➑ How has the covid-19 impacted the growth of the market? ➒ Has the supply chain disruption caused changes in the entire value chain? Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@stringentdatalytics.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1 346 666 6655 to share your research requirements.

About Stringent Datalytics

Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client's needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations.

Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs.

Reach US

Stringent Datalytics

sales@stringentdatalytics.com

+1 346 666 6655

Social Channels:

Linkedin | Facebook | Twitter | YouTube